ASTH
Astrana Health, Inc. Industrials Services-Management Consulting Services Russell 3000
$36.53Close
$1.8BMarket cap
$18.16 – $49.8152-week range
Nov 5, 2026Next report · after the close
Highlights
Strengths
- Earnings growing EPS +108% year on year
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Far from its high 27% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
27%
1wk
down 2.5%
price change
1mo
up 2.7%
price change
12-month return
up 15%
market up 11% ·
its own down 1%
F-score
—
— Not assessed
Altman Z″
1.92
Moderate risk
P/E
74.4×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.3×
price / book
Earnings yield
up 3.3%
EBIT / enterprise value
Cheaper than
62%
of the market · cheap
Revenue growth
up 56%
year on year
EPS growth
up 108%
latest quarter · -7 pts
Sales growth
up 49%
latest quarter · -7 pts
ROE
up 3%
return on equity
Free cash margin
up 3%
$104.5M FCF
D/E
1.27
long-term debt / equity
Net debt / EBITDA
4.5×
Interest cover
—EBIT / interest
Trade setup
ATR%
4.1%
$1.50 a day · 2×ATR $33.53
RS
72 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
0.88
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Heavily indebted Net debt is 4.5 times EBITDA — roughly 5 years of earnings before interest, tax and depreciation to repay borrowings in full.
Last reported
Aug 6, 2026
Last shock
Sep 17, 2026-9% in one session2.3× volumeon an SEC filing+7% since
Financials
- Gross
- Net 1%
- Free cash 3%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $687.2M | $773.9M | $1.1B | $1.4B | $2.0B | $3.2B |
| Gross margin | 22% | 23% | — | — | — | — |
| Operating income | $80.5M | $98.2M | $104.3M | $84.6M | $89.3M | $78.5M |
| Net income | $37.7M | $46.0M | $46.0M | $58.0M | $50.0M | $24.0M |
| Net margin | 5% | 6% | 4% | 4% | 2% | 1% |
| Earnings per share | $1.01 | $1.01 | $1.01 | $1.24 | $1.04 | $0.49 |
| Free cash flow | $45.0M | $51.1M | $59.2M | $39.7M | $44.2M | $104.5M |
| Free cash margin | 7% | 7% | 5% | 3% | 2% | 3% |
| Cash | $193.5M | $233.1M | $288.0M | $293.8M | $288.5M | $429.5M |
| Long-term debt | $230.2M | $182.9M | $203.4M | $258.9M | $425.3M | $990.9M |
| Shareholders' equity | $330.8M | $448.2M | $542.6M | $614.2M | $712.7M | $779.3M |
| Shares outstanding | 42.25m | 44.63m | 46.58m | 46.84m | 47.93m | 48.89m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 10, 2026 | Quarterly ↗ | Jun 30, 2026 | 41d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Mar 12, 2026 | Annual ↗ | Dec 31, 2025 | 71d |
| Nov 10, 2025 | Quarterly ↗ | Sep 30, 2025 | 41d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Mar 14, 2025 | Annual ↗ | Dec 31, 2024 | 73d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 23, 2026 | Regulation FD ↗ |
| Sep 23, 2026 | Cybersecurity incident ↗ |
| Sep 15, 2026 | Regulation FD ↗ |
| Aug 6, 2026 | Results · Regulation FD ↗ |
| Jul 13, 2026 | Regulation FD ↗ |
| Jul 1, 2026 | Director or officer change ↗ |
| Jun 10, 2026 | Director or officer change · Shareholder vote ↗ |
| May 12, 2026 | Director or officer change ↗ |
| May 12, 2026 | Regulation FD ↗ |
| May 7, 2026 | Results · Regulation FD ↗ |
| Mar 30, 2026 | Other events ↗ |
| Mar 4, 2026 | Regulation FD ↗ |